78 T-Cell, MHC i, and tumor intrinsic gene signatures predict clinical benefit and resistance to tislelizumab monotherapy in pretreated PD-L1+ urothelial carcinoma

78 T-Cell, MHC i, and tumor intrinsic gene signatures predict clinical benefit and resistance to tislelizumab monotherapy in pretreated PD-L1+ urothelial carcinoma

Bibliographic Details
Main Authors: Yun Zhang, Jian Huang, Pei Zhang, Hanzhong Li, Ruiqi Huang, Wei Shen, Aiping Zhou, Dingwei Ye, Xiaopeng Ma, Qing Zou, Cheng Fu, Hailong Hu, Xiusong Qiu, Lilin Zhang, Feng Bi
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer

Similar Items